Self-reported alcohol use and depressive symptoms after liver transplantation.

Background: The prevalence of alcohol use among Finnish liver transplant recipients has not been studied before.

Methods: We used self-report questionnaires and correlations between alcohol use liver biochemistry and depressive symptoms at the only transplant unit of the country, during a 6-month period in 2013.

Results: The final study population consisted of 207 recipients.

Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report.

In this case report, even a moderate dose of dexmedetomidine, a very selective alpha(2)-adrenergic agent, resulted in a rapid response to alcohol withdrawal delirium after the standard treatment. Psychiatrists should be aware of this relatively new drug that provides advantages over clonidine, heavy sedation and secondary restraints. Dexmedetomidine should be further evaluated in the treatment of specific forms of aggressive behavior and complicated withdrawal states.

[Evaluation of Swedish and Finnish web portals for physicians. The usability is considerable but there are problems with privacy and ethics].

A critical overview of Swedish and Finnish medical web portals for doctors is presented in this article. Three Swedish and three Finnish portals were analysed using 54 dichotomous questions, derived from the guidelines of the American Medical Association (AMA), and 17 technical heuristic questions for web usability. 34 portal features were cross-tabulated with all portals.